| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/15/2004 | WO2004003012A3 Novel variants of the papm polypeptide of bacteria of genus streptomyces |
| 04/15/2004 | WO2004002509A3 Use of casein peptides for treating hypertension |
| 04/15/2004 | WO2004000875A3 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders |
| 04/15/2004 | WO2003106488A3 Antagonists of cxr3-binding cxc chemokines |
| 04/15/2004 | WO2003104381A3 Methods for the detection of polymorphisms in human gpr50 |
| 04/15/2004 | WO2003103704A3 L(2)44 dea, wunen-2, grapes, cg2221, cg1172, rutabaga, cg11940, facl involved in the regulation of energy homeostasis |
| 04/15/2004 | WO2003103588A3 Methods of using artemisinin-like compounds to prevent or delay the appearance of cancer |
| 04/15/2004 | WO2003103581A3 Compositions and methods for liver growth and liver protection |
| 04/15/2004 | WO2003102579A3 Method of screening groups of radioactive molecules and applications thereof |
| 04/15/2004 | WO2003099845A3 Fas peptide mimetics and uses thereof |
| 04/15/2004 | WO2003094849A3 Ferritin fusion proteins for use in vaccines and other applications |
| 04/15/2004 | WO2003092603B1 Composition and method for reducing post-prandial blood glucose |
| 04/15/2004 | WO2003091266A3 Protein stabilisation using chaperone proteins |
| 04/15/2004 | WO2003089457B1 Peptide inhibitors of protein kinase c ϝ for pain management |
| 04/15/2004 | WO2003087325A3 Methods and compositions for preventing and treating microbial infections |
| 04/15/2004 | WO2003087157A3 Differentially expressed genes involved in angiogenesis, the proteins encoded thereby, and methods of using the same |
| 04/15/2004 | WO2003082392A3 Oxygenating agents for enhancing host responses to microbial infections |
| 04/15/2004 | WO2003068807A3 Echinocandin cyclic peptide derivatives |
| 04/15/2004 | WO2003066807A3 Method of inhibiting pathogenicity of infectious agents |
| 04/15/2004 | WO2003065010B1 Identification of epitopes on staphylococcal enterotoxins that inhibit transcytosis |
| 04/15/2004 | WO2003051309A3 Antisense modulation of abc transporter mhc 1 expression |
| 04/15/2004 | WO2003049717A3 Conductance of improperly folded proteins through the secretory pathway and related treatments of diseases |
| 04/15/2004 | WO2003044163A3 Antisense modulation of toll-like receptor 4 expression |
| 04/15/2004 | WO2003043580A3 Methods for identifying and validating potential drug targets |
| 04/15/2004 | WO2003030834A3 Cyclosporin analogs for the treatment of lung diseases |
| 04/15/2004 | WO2003028527A8 Diagnostic or therapeutic somatostatin or bombesin analog conjugates and uses thereof |
| 04/15/2004 | WO2003022217A9 Treatment of excessive radiation (e.g. sunburn) exposure |
| 04/15/2004 | WO2003018823A8 Obesity related genes expressed at least in the hypotalamus, liver or pancreas |
| 04/15/2004 | WO2003017825A3 Methods of treating obesity |
| 04/15/2004 | WO2003008038A9 Electro-medical device for use with biologics |
| 04/15/2004 | WO2003006057A8 Composition and method for the treatment of disease |
| 04/15/2004 | WO2003004604A9 Phage displayed pdz domain ligands |
| 04/15/2004 | WO2002102975A3 Dna molecules and recombinant dna molecules for producing humanized monoclonal antibodies to s. mutans |
| 04/15/2004 | WO2002102405B1 The use of bacterial phage associated lytic enzymes to prevent food poisoning |
| 04/15/2004 | WO2002081703A9 Mitogenic oxygenase regulators |
| 04/15/2004 | WO2002080962A8 Papaine containing pharmaceutical formulation resp. its use |
| 04/15/2004 | WO2002072757A3 Novel proteins and nucleic acids encoding same |
| 04/15/2004 | WO2002055706A3 Asip-related proteins |
| 04/15/2004 | WO2002018424A9 Nucleic acids and polypeptides |
| 04/15/2004 | WO2002016553B1 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 04/15/2004 | WO2001019852A8 Methods of peptide preparation |
| 04/15/2004 | US20040073965 Regulatory element from a sugarcane proline rich protein and used thereof |
| 04/15/2004 | US20040073959 Genetic control of sex ratio in animal populations |
| 04/15/2004 | US20040073160 Intradermal delivery of substances |
| 04/15/2004 | US20040073025 Thrombin inhibitors |
| 04/15/2004 | US20040073016 Compositions and methods for the therapy and diagnosis of breast cancer |
| 04/15/2004 | US20040073015 Comprises nucleotide sequences coding membrane protein for use in the treatment, diagnosis and prevention of cell proliferative, nervous system, autoimmune and cardiovascular disorders |
| 04/15/2004 | US20040073013 Polypeptide inducing apoptosis |
| 04/15/2004 | US20040073012 Monoclonal antibody for diagnosis and treatment of glomerulonephritis, autoimmune and allergic diseases |
| 04/15/2004 | US20040073008 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 04/15/2004 | US20040073007 Antiangiogenic peptides |
| 04/15/2004 | US20040073005 Ti-3 protein derived from triatoma infestans exhibiting activity to inhibit platelet aggregation |
| 04/15/2004 | US20040073001 Beta-catenin nuclear localized protein |
| 04/15/2004 | US20040073000 Genes and proteins, and their uses |
| 04/15/2004 | US20040072997 Therapeutic polypeptides, nucleic acids encoding same, and methods of use |
| 04/15/2004 | US20040072996 Comprises membrane protein for diagnosis, prevention and treatment of cell proliferative, nervous system, gastrointestinal, autoimmue and metabolic disorders |
| 04/15/2004 | US20040072993 Identifying modulator of chimeric chaperone protein for treatment and diagnosis of immune, cell proliferative and infectious disorders |
| 04/15/2004 | US20040072992 Novel peptide capable of specifically acting on biological membrane |
| 04/15/2004 | US20040072991 Mimetic polypeptide for treatment and prevention of nervous system disorders |
| 04/15/2004 | US20040072990 Antimicrobial peptides with reduced hemolysis and methods of their use |
| 04/15/2004 | US20040072986 Ring opening polymerization of lactide, glycolide in presence of dextran sulfate in an extruder; sustained release; drug delivery |
| 04/15/2004 | US20040072961 Multiblock biodegradable hydrogels for drug delivery and tissue treatment |
| 04/15/2004 | US20040072885 Treatments for immune-mediated ear disorders |
| 04/15/2004 | US20040072821 N-substituted glycine derivatives |
| 04/15/2004 | US20040072816 Dysmenorrhea; congestive heart failure; liver disorders; vision defects |
| 04/15/2004 | US20040072814 Method for obtaining a natural mixture of conjugated equine estrogens depleted in non-conjugated lipophilic compounds |
| 04/15/2004 | US20040072809 Antiinflammatory agents; analgesics; dilation; reducing pressure; therapy for vision defects |
| 04/15/2004 | US20040072805 Use of tumor necrosis factor inhibitors to treat cardiovascular disease |
| 04/15/2004 | US20040072788 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/15/2004 | US20040072787 Cancer |
| 04/15/2004 | US20040072785 Ischemia; polynucleotide for transfection; polynucleotide is inserted into an artery or a vein; prior to injection the volume of the muscle tissue is increased such that the genetic material is delivered to the parenchymal cell |
| 04/15/2004 | US20040072783 DNA catalysts, DNA enzymes; to target virtually any RNA transcript; for cleavage of RNA or DNA; do not share sequence homology with other known DNA enzymes |
| 04/15/2004 | US20040072780 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 04/15/2004 | US20040072779 A mammalian target gene and an exogenous oligoribonucleotide having a double stranded RNA; complementary region I is less than 49 nucleotides in length; cancer, viral diseases, neurodegenerative diseases |
| 04/15/2004 | US20040072778 Prognosis of neuroblastoma; antisense nucleic acids for malignant tumors |
| 04/15/2004 | US20040072777 Nucleic acid sequence to treat infections of the epididymis |
| 04/15/2004 | US20040072776 Antisense insulin-like growth factor binding protein (igfbp)-2-oligodeoxynucleotides for prostate and other endocrine tumor therapy |
| 04/15/2004 | US20040072775 Enhancing the sensitivity of tumor cells to therapies |
| 04/15/2004 | US20040072774 Methods for expressing and targeting mitochondrial-DNA-encoded peptides and uses thereof |
| 04/15/2004 | US20040072773 Novel functions for dp214 |
| 04/15/2004 | US20040072772 Survival Regulating Kinase, SRK, involved in cell signal transduction; method of detecting a protein kinase activity in a human SRK polypeptide |
| 04/15/2004 | US20040072771 Ex vivo gene therapy; HIV infection; at least 1.63 x 106 CD34+ hematopoietic cells (per kg of body weight) being transduced with a viral construct which expresses an anti-HIV agent |
| 04/15/2004 | US20040072770 Methods for specifically inhibiting histone deacetylase-7 and 8 |
| 04/15/2004 | US20040072768 Screening for the ability of a putative compound to inhibit induction of Egr-1, decrease expression of Egr-1 or decrease the nuclear accumulation or activity of the Egr-1 gene product; antisense oligonucleotides |
| 04/15/2004 | US20040072766 Bioassay for screening an inhibitor or activator of phosphatidylinositol 3-kinase, finding immunostimulants, or immunosuppressants |
| 04/15/2004 | US20040072761 Heterocyclicsulfonamide hepatitis C virus inhibitors |
| 04/15/2004 | US20040072759 Polypeptides |
| 04/15/2004 | US20040072758 Contulakin-G, analogs thereof and uses therefor |
| 04/15/2004 | US20040072757 Agents affecting thrombosis and hemostasis |
| 04/15/2004 | US20040072755 A fusion proteins, a binding proteins as anticarcinogenic agents for treating cancer, antiinflammatory agents, treating atherosclerosis and ischemia/ reperfusion |
| 04/15/2004 | US20040072754 A non-glycosylated peptide, a cell or a vector comprising a polynucleotide construct encoding the protein, for use as antitumor agents, anticarcinogenic agents |
| 04/15/2004 | US20040072753 Peptides for use in the treatment of alzheimer's disease |
| 04/15/2004 | US20040072752 Providing the amelioration of symptoms, caused by gene overexpression of encoding a cytokine suppressor; treating rheumatoid arthritis |
| 04/15/2004 | US20040072751 A kits for use in drug screening antagonists, agonists; a recombinant vector polynucleotide, cell culturing, an antibody used for diagnostic, for adjusting the expression of the G protein-coupled receptor protein |
| 04/15/2004 | US20040072750 Administering an antibodies of antigen protein as thrombolytic agents, anticoagulants |
| 04/15/2004 | US20040072748 Methods and compositions for the treatment and prevention of Staphylococcus and other bacterial infections |
| 04/15/2004 | US20040072745 Biodrug treatment or prevention of skin disorders caused by wounds, skin diseases, sepsis, inflammation, allergies, immunodeficiencies, autoimmune diseases, infections; using polypepetides or epitope recognizing antibody |
| 04/15/2004 | US20040072744 Synthetic peptide as treatment for down's syndrome and schizophrenia |
| 04/15/2004 | US20040072743 Pharmaceutical composition of modified pna molecules |
| 04/15/2004 | US20040072742 Novel gene and use thereof |